Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2020   24,850,261      
Beginning balance at Dec. 31, 2020 $ 17,242,484 $ 24,850 $ 56,814,428 $ (39,529,621) $ (42,323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 39,085   39,085    
Distributions to Noncontrolling interests (18,176)       18,176
Net income (11,796)     (1,766,707)  
Net income (loss) 1,778,503       11,796
Ending balance (shares) at Mar. 31, 2021   24,850,261      
Ending balance at Mar. 31, 2021 19,066,746 $ 24,850 56,853,513 (37,762,914) (48,703)
Beginning balance (shares) at Dec. 31, 2021   24,850,261      
Beginning balance at Dec. 31, 2021 21,128,149 $ 24,850 57,016,859 (35,833,621) (79,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation expense 95,707   95,707    
Distributions to Noncontrolling interests (15,640)       (15,640)
Net income (10,159)     (89,409)  
Net income (loss) 99,568       10,159
Ending balance (shares) at Mar. 31, 2022   24,850,261      
Ending balance at Mar. 31, 2022 $ 21,307,784 $ 24,850 $ 57,112,566 $ (35,744,212) $ (85,420)